SCHEMBL22494493

SCHEMBL22494493

O=C(O)c1ccc2cc(C(=O)NC3CCCCC3)ccc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.59
RAB9A P51151 9/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
HPGD P15428 3/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2C19 P33261 1/20 0.59
TP53 P04637 1/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
PKM P14618 1/20 0.57
SMYD3 Q9H7B4 1/20 0.57
HRH3 Q9Y5N1 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ALDH1A1 P00352 1/20 0.55
TSHR P16473 1/20 0.55
LMNA P02545 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL127203 0.95 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL124356 0.95 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL28658639 0.95 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL517344 0.95 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL29380975 0.95 NPC1 (0.65) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL518025 0.93 SMYD3 (0.63) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL517341 0.90 NPC1 (0.63) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL29818792 0.89 NPC1 (0.62) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL3031654 0.89 NPC1 (0.58) NPC1RAB9ASMN1; SMN2HPGDCYP1A2
SCHEMBL7928067 0.89 NPC1 (0.62) NPC1RAB9ASMN1; SMN2HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999454-B High-toughness polypropylene composite material capable of inhibiting space charge and preparation method thereof 清华大学 2022-08-30 CN claimed
US-11591450-B2 Method for stabilizing halogen-free thermoplastic recyclates, stabilized plastic compositions, and molding compounds and molded parts produced therefrom Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-02-28 US disclosed
CN-115362142-A Use of substituted cinnamates as stabilizers for organic materials, stabilized organic materials, methods of stabilizing organic materials, and specific cinnamates 弗劳恩霍夫应用研究促进协会 2022-11-18 CN disclosed
US-11407720-B2 Compounds having a stabilizing effect, method for producing said compounds, composition containing said stabilizing compounds, and uses of the compounds Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2022-08-09 US disclosed
US-11358941-B2 2022-06-14 US disclosed
US-20220119624-A1 METHOD OF STABILIZING HALOGEN-FREE THERMOPLASTIC RECYCLATES, PLASTICS COMPOSITION, STABILIZER COMPOSITION AND USE OF THE STABILIZER COMPOSITION Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) 2022-04-21 US disclosed
US-20200361879-A1 COMPOUNDS HAVING A STABILIZING EFFECT, METHOD FOR PRODUCING SAID COMPOUNDS, COMPOSITION CONTAINING SAID STABILIZING COMPOUNDS, METHOD FOR STABILIZING AN ORGANIC COMPONENT, AND USE OF STABILIZING COMPOUNDS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) 2020-11-19 US disclosed
US-20200317886-A1 METHOD FOR STABILIZING HALOGEN-FREE THERMOPLASTIC RECYCLATES, STABILIZED PLASTIC COMPOSITIONS, AND MOLDING COMPOUNDS AND MOLDED PARTS PRODUCED THEREFROM Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e. V. (DE) 2020-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11407720-B2 Compounds having a stabilizing effect, method for producing said compounds, composition containing said stabilizing compounds, and uses of the compounds OGG1, SOD1, ERCC5 NPC1 949/4885RAB9A 2514/4885SMN1; SMN2 322/4885
US-11358941-B2 OGG1, SOD1, ERCC5 NPC1 1301/4885RAB9A 2784/4885SMN1; SMN2 589/4885
US-20200361879-A1 COMPOUNDS HAVING A STABILIZING EFFECT, METHOD FOR PRODUCING SAID COMPOUNDS, COMPOSITION CONTAINING SAID STABILIZING COMPOUNDS, METHOD FOR STABILIZING AN ORGANIC COMPONENT, AND USE OF STABILIZING COMPOUNDS OGG1, SOD1, AOX1 NPC1 1138/4885RAB9A 2832/4885SMN1; SMN2 380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.